Answers are grounded in this paper and cite their sources.
Bone metastatic prostate cancer remains a major clinical challenge due to the lack of physiologically relevant models that are compatible with high-throughput drug discovery workflows. Conventional two-dimensional (2D) culture systems enable scalable, reproducible screening but fail to recapitulate the structural, mechanical and biological complexity of the bone metastatic niche. Here, we developed a biomimetic eggshell-chitosan-poly (ethylene glycol) diacrylate (EC-PEGDA) scaffold designed to support three-dimensional (3D) investigation of prostate cancer-associated tumour–stroma interactions within a bone mimetic microenvironment, while remaining compatible with standard multiwell formats and confocal imaging. Micro-computed tomography (MicroCT) and SEM demonstrated that the scaffold possessed a biologically relevant bone volume/total volume (BV/TV; 91.75 ± 1.219). Biological evaluation demonstrated cytocompatibility with multiple cell lines associated with the metastatic niche, including PC-3, LNCaP, HS-5 and hFOB1.19 cells. Distinct morphologies and multicellular spheroids were identified within the scaffolds, and osteoblastic activity was observed but was reduced when co-cultured with PC-3 cells, consistent with metastatic tumour–bone interactions. Importantly, the model supported tumour–stroma cytokine signalling, with elevated net concentrations of GM-CSF, IL-1β and TNF-α observed in HS-5-containing cultures exposed to PC-3-conditioned media. These findings indicate cytokine responses associated with tumour-derived soluble factors within the bone-mimetic microenvironment. Conditioned media studies demonstrated that tumour-derived soluble factors were sufficient to promote increased cytokine concentrations in the absence of direct cell–cell contact. Collectively, these findings demonstrate that the EC-PEGDA scaffold provides an imaging-compatible and structurally relevant bone-mimetic microenvironment capable of supporting multicellular culture and tumour-associated cytokine signalling. While the model does not fully reproduce the complexity of metastatic bone disease, it captures key aspects of tumour–stroma communications and provides a reproducible platform for investigating mechanisms relevant to prostate cancer progression within the bone.
No takes yet. Share an insight, caveat, or question.
Reinke et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: